+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Meningococcal Vaccines Market Research Report by Type, by Category, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4857895
  • Report
  • July 2021
  • Region: Global
  • 191 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Meningococcal Vaccines Market will Grow to USD 9,405.31 Million by 2026, at a CAGR of 12.79%

FEATURED COMPANIES

  • Bio-Manguinhos
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
The Global Meningococcal Vaccines Market size was estimated at USD 4,567.28 Million in 2020 and expected to reach USD 5,136.17 Million in 2021, at a Compound Annual Growth Rate (CAGR) 12.79% to reach USD 9,405.31 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Meningococcal Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Meningococcal Vaccines Market was studied across Combination Vaccines, Conjugate Vaccines, Men B Vaccines, and Polysaccharide Vaccines. The Combination Vaccines is further studied across MenHibrix and Menitorix. The Conjugate Vaccines is further studied across Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, and NmVac4-DT. The Men B Vaccines is further studied across Bexsero and Trumenba. The Polysaccharide Vaccines is further studied across Mencevax, Menomune, and NmVac4.
  • Based on End User, the Meningococcal Vaccines Market was studied across Hospital Pharmacies, Pediatric Clinic, and Retail Pharmacies.
  • Based on Category, the Meningococcal Vaccines Market was studied across Intramuscular and Subcutaneous.
  • Based on Region, the Meningococcal Vaccines Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Meningococcal Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Meningococcal Vaccines Market, including Bio-Manguinhos, Chongqing Zhifei Biological Products Co., Ltd., GlaxoSmithKline PLC, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Ltd., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd., and Walvax Biotechnology Co., Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Meningococcal Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Meningococcal Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Meningococcal Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Meningococcal Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Meningococcal Vaccines Market?
6. What is the market share of the leading vendors in the Global Meningococcal Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the Global Meningococcal Vaccines Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bio-Manguinhos
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. End User Outlook
3.5. Category Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of meningitis across the world
5.1.1.2. Presence of various government and healthcare interventions for the awareness of Meningococcal diseases
5.1.1.3. Rising R&D activities and vaccines developments in the pipeline
5.1.2. Restraints
5.1.2.1. Stringent government regulations for the approval of vaccines
5.1.3. Opportunities
5.1.3.1. Incidence of bacterial meningitis in emerging countries
5.1.3.2. Elevation of collaborations and partnerships to support the development of the vaccines
5.1.4. Challenges
5.1.4.1. High cost associated with the development of the meningococcal vaccines
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Meningococcal Vaccines Market, by Type
6.1. Introduction
6.2. Combination Vaccines
6.2.1. MenHibrix
6.2.2. Menitorix
6.3. Conjugate Vaccines
6.3.1. Menactra
6.3.2. MenAfriVac
6.3.3. Meningitec
6.3.4. Menjugate
6.3.5. Menveo
6.3.6. NeisVac-C
6.3.7. Nimenrix
6.3.8. NmVac4-DT
6.4. Men B Vaccines
6.4.1. Bexsero
6.4.2. Trumenba
6.5. Polysaccharide Vaccines
6.5.1. Mencevax
6.5.2. Menomune
6.5.3. NmVac4

7. Meningococcal Vaccines Market, by End User
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Pediatric Clinic
7.4. Retail Pharmacies

8. Meningococcal Vaccines Market, by Category
8.1. Introduction
8.2. Intramuscular
8.3. Subcutaneous

9. Americas Meningococcal Vaccines Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Meningococcal Vaccines Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Meningococcal Vaccines Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Bio-Manguinhos
13.2. Chongqing Zhifei Biological Products Co., Ltd.
13.3. GlaxoSmithKline PLC
13.4. Hualan Biological Engineering Inc.
13.5. Incepta Pharmaceuticals Ltd.
13.6. Merck & Co., Inc.
13.7. Pfizer Inc.
13.8. Sanofi S.A.
13.9. Serum Institute of India Ltd.
13.10. Walvax Biotechnology Co., Ltd.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2020 (USD MILLION)
FIGURE 5. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 6. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL MENINGOCOCCAL VACCINES MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL MENINGOCOCCAL VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 10. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2026
FIGURE 12. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 46. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 48. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 50. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 51. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2026
FIGURE 53. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 54. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 55. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, 2018-2026 (USD MILLION)
FIGURE 56. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 57. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 58. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 59. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2020 VS 2026 (%)
FIGURE 60. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2020 VS 2026 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2026
FIGURE 62. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, 2018-2026 (USD MILLION)
FIGURE 63. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 64. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, 2018-2026 (USD MILLION)
FIGURE 65. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 66. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 84. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 85. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 86. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 87. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 88. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 89. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 90. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 91. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 92. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 93. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 94. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 95. GLOBAL MENINGOCOCCAL VACCINES MARKET: FPNV POSITIONING MATRIX
FIGURE 96. GLOBAL MENINGOCOCCAL VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 97. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MENINGOCOCCAL VACCINES MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL MENINGOCOCCAL VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2026 (USD MILLION)
TABLE 27. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 28. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 58. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 59. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 60. GLOBAL MENINGOCOCCAL VACCINES MARKET: SCORES
TABLE 61. GLOBAL MENINGOCOCCAL VACCINES MARKET: BUSINESS STRATEGY
TABLE 62. GLOBAL MENINGOCOCCAL VACCINES MARKET: PRODUCT SATISFACTION
TABLE 63. GLOBAL MENINGOCOCCAL VACCINES MARKET: RANKING
TABLE 64. GLOBAL MENINGOCOCCAL VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 65. GLOBAL MENINGOCOCCAL VACCINES MARKET: MERGER & ACQUISITION
TABLE 66. GLOBAL MENINGOCOCCAL VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 67. GLOBAL MENINGOCOCCAL VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 68. GLOBAL MENINGOCOCCAL VACCINES MARKET: INVESTMENT & FUNDING
TABLE 69. GLOBAL MENINGOCOCCAL VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 70. GLOBAL MENINGOCOCCAL VACCINES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Bio-Manguinhos
  • Chongqing Zhifei Biological Products Co., Ltd.
  • GlaxoSmithKline PLC
  • Hualan Biological Engineering Inc.
  • Incepta Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Ltd.
  • Walvax Biotechnology Co., Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll